Replies to post #893 on Todos Med Ltd (TOMDF)

[Roily23]

The race is on. TODOS better move quick:

ABBOTT LAUNCHES MOLECULAR POINT-OF-CARE TEST TO DETECT NOVEL CORONAVIRUS IN AS LITTLE AS FIVE MINUTES
- The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines
- Test to run on Abbott's point-of-care ID NOW platform - a portable instrument that can be deployed where testing is needed most
- ID NOW has the largest molecular point-of-care installed base in the U.S. and is available in a wide range of healthcare settings
- Abbott will be making ID NOW COVID-19 tests available next week and expects to ramp up manufacturing to deliver 50,000 tests per day
- This is the company's second test to receive Emergency Use Authorization by the FDA for COVID-19 detection; combined, Abbott expects to produce about 5 million tests per month

https://www.abbott.com/corpnewsroom/product-and-innovation/detect-covid-19-in-as-little-as-5-minutes.html